STOCK TITAN

Silence Therapeutics Plc Stock Price, News & Analysis

SLNCF OTC Link

Company Description

Welcome to the overview page for Silence Therapeutics Plc (SLNCF), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—
0.00%
0.00
Last updated:
+54.87%
Performance 1 year
$226.7M

Financial Highlights

$43.3M
Revenue (TTM)
-$45.3M
Net Income (TTM)
-$67.6M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in Silence Therapeutics Plc (SLNCF) currently stands at 755 shares, up 1000.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 287.2%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for Silence Therapeutics Plc (SLNCF) currently stands at 1.7 days, up 72% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 91.2% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 19.5 days.

Frequently Asked Questions

What is the current stock price of Silence Therapeutics Plc (SLNCF)?

The current stock price of Silence Therapeutics Plc (SLNCF) is $1.75 as of February 27, 2026.

What is the market cap of Silence Therapeutics Plc (SLNCF)?

The market cap of Silence Therapeutics Plc (SLNCF) is approximately 226.7M. Learn more about what market capitalization means .

What is the revenue (TTM) of Silence Therapeutics Plc (SLNCF) stock?

The trailing twelve months (TTM) revenue of Silence Therapeutics Plc (SLNCF) is $43.3M.

What is the net income of Silence Therapeutics Plc (SLNCF)?

The trailing twelve months (TTM) net income of Silence Therapeutics Plc (SLNCF) is -$45.3M.

What is the earnings per share (EPS) of Silence Therapeutics Plc (SLNCF)?

The diluted earnings per share (EPS) of Silence Therapeutics Plc (SLNCF) is $-0.33 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Silence Therapeutics Plc (SLNCF)?

The operating cash flow of Silence Therapeutics Plc (SLNCF) is -$67.6M. Learn about cash flow.

What is the profit margin of Silence Therapeutics Plc (SLNCF)?

The net profit margin of Silence Therapeutics Plc (SLNCF) is -104.7%. Learn about profit margins.

What is the operating margin of Silence Therapeutics Plc (SLNCF)?

The operating profit margin of Silence Therapeutics Plc (SLNCF) is -146.4%. Learn about operating margins.

What is the gross margin of Silence Therapeutics Plc (SLNCF)?

The gross profit margin of Silence Therapeutics Plc (SLNCF) is 72.7%. Learn about gross margins.

What is the current ratio of Silence Therapeutics Plc (SLNCF)?

The current ratio of Silence Therapeutics Plc (SLNCF) is 11.14, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Silence Therapeutics Plc (SLNCF)?

The gross profit of Silence Therapeutics Plc (SLNCF) is $31.4M on a trailing twelve months (TTM) basis.

What is the operating income of Silence Therapeutics Plc (SLNCF)?

The operating income of Silence Therapeutics Plc (SLNCF) is -$63.3M. Learn about operating income.